Sponsor Pipeline

BreakBio Corp Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-13 NCT07762703 Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic… Phase 1/2 Not Yet Recruiting
2026-08-13 NCT07762716 Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07762703 Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic… Triple-Negative Breast Cancer (TNBC) Not Yet Recruiting
NCT07762716 Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment… Glioblastoma (GBM) Not Yet Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1) Glioblastoma (1)
Get alerts when BreakBio Corp's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free